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g.2012.1Abstract Mitochondrial DNA-associated Leigh syndrome is a part of a continuum of progressive
neurodegenerative disorders caused by abnormalities of mitochondrial energy generation. Mito-
chondrial T8993C and T8993G mutations account for 10–20% of these cases. T8993C is generally
associated with milder phenotype than T8993G mutation. Here we report an Egyptian family with
T8993C mutation with unusual early onset of severe phenotype in three sisters (consisting of regres-
sion of previously acquired motor and mental milestones after an attack of viral infection) and
hypothyroidism as the only presenting symptom in their brother. The mother (like her son) carried
the T8993C mutation and was asymptomatic. This unusual lack of manifestation could be attrib-
uted to different percentages of mutated mitochondrial DNA in the brain or muscle or perhaps
to some unknown protective factor. The hypothyroidism could be a simple association, but to
the best of our knowledge, no previous reports have described hypothyroidism in carriers of this
mutation.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.Case report
We report an 8 year old Egyptian girl, 4th child of non consan-
guineous parents, born by elective cesarean section with unre-
markable antenatal and postnatal periods. Her milestonesedical Genetics Center, 27A
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Shams University.
g by Elsevier
y. Production and hosting by Elsev
0.005were achieved very satisfactorily until the age of 4 years when
she developed severe upper respiratory tract infection and after
2 weeks developed hematemesis and melena, and became ﬂop-
py, with marked regression in her previously acquired develop-
mental milestones. She became aphasic together with gradual
deterioration of the level of consciousness. She was admitted
to the intensive care unit for 45 days without the need for
mechanical ventilation and was discharged non-ambulatory.
Her condition has been stable since then and she has even
shown some improvement. On examination, her weight and
length were below the 5th percentile. She was alert, and could
ﬁx and follow visual stimuli. She responded to auditory stimuli
and interacted appropriately with her surroundings. She was
aphasic though she understood and performed simple orders.ier B.V. All rights reserved.
Figure 1 T2WI FLAIR (a) and T2WI (b) magnetic resonance imaging showing focal zones of abnormal signal (high on T2-weighted
images) within the basal ganglia.
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tion showed no abnormality. Her muscle bulk was clearly re-
duced with atrophy and a generalized increase in muscle
tone and weakness. Though, she was moving freely in bed,
she could barely move her arms and thighs against gravity.
Her hand manipulation and ﬁne hand movements were better
than her proximal movement. Deep tendon reﬂexes were brisk
with left patellar clonus, bilaterally positive Babinski and in-
tact abdominal reﬂexes. The girl was non-ambulatory with
no evidence of limb ataxia. There was no limb deformity or
abnormal involuntary movements. She could appreciate pain
in all sensory dermatomes.
Chest heart and abdominal examination was clinically free.
An initial work up was done including serum electrolytes, li-
ver and kidney function tests, and ammonia level which all re-
vealed normal results. Serum lactate was elevated (50 mg/dl
and 40 mg/dl in two separate occasions). Screening for amino-
acidopathies and fatty acid oxidation defects was normal.
Also, urine organic acid testing showed no abnormalities.
Needle EMG and conduction studies were not suggestive of
any deﬁnite pathology. MRI brain showed mild diffuse volume
loss with prominent cortical sulci and extraaxial CSF spaces
and cerebellar folia. Bilateral focal zones of abnormal signal
within the basal ganglia were present. These zones appeared
with high signal on T2-weighted images, low signal on T1
and showed diffusion restriction producing intense bright sig-
nals on diffusion-weighted images (Fig. 1).
The child had a very signiﬁcant family history. Her eldest
brother was diagnosed soon after birth in the National neona-
tal screening program with congenital hypothyroidism and re-
ceived L-thyroxine since then and was otherwise comparable
to peers. The second sib was a female who was also normal un-
til the age of 8 months when she developed upper respiratory
tract infection, vomiting and diarrhea which did not respond
to treatment. After 30 days, she developed fever and seizures,
and progressed to loss of consciousness. She was admitted to
the PICU where she developed thrombocytopenia and hepato-
cellular failure and died 13 days after admission. The third sib
was also a female, who was normal until the age of 1.5 years
when she also developed upper respiratory tract infection
and irritability then started to have vomiting and diarrhea
for 20 days, then progressed to fever and loss of consciousness.
She died within 2 months of progression of her illness. During
the period of her admission, investigations including complete
blood count, electrolytes, blood sugar, liver and kidney func-
tion tests, and CSF analysis (for protein, sugar and chloride,
and culture), were within normal. Serum ammonia, plasmaand urine amino acid proﬁle were within normal. However,
serum lactate showed mild elevation (26 mg/dl). MRI brain
showed multiple signal alteration (hyperintense in T1 and
T2-W) areas in the basal ganglia on both sides and central por-
tions of midbrain, suggestive of Leigh syndrome.
Thus taking all data into consideration, the patient and her
older two sisters seemed to ﬁt the stringent diagnostic criteria
for Leigh syndrome that were deﬁned by Rahman et al. [1].
And so molecular testing for mitochondrial DNA-associated
Leigh syndrome was done.Molecular testing methods
Whole cellular DNA was extracted from blood or tissue and
subjected to ampliﬁcation by PCR using primers which ﬂank
position 8993 in the mitochondrial DNA. The PCR product
was digested with restriction endonuclease Msp I which cuts
the product if the nucleotide at position 8993 is mutated from
T to G or T to C. After digestion, the DNA products were sub-
jected to electrophoresis through agarose and visualized with
ethidium bromide. When analyzed by this method, DNA from
normal individuals gives only one band, of 551 base pairs.
DNA from individuals carrying an 8993 NARP mutation gives
three bands, the normal 551 base pair band and two abnormal
bands, 345 and 206 base pairs in length, which result from
cleavage of the mutated portion of the products by Msp I. In
this case an abnormal banding pattern was seen, and so the T
to G mutation was differentiated from the T to C mutation
by digestion of the PCR product with Ava I, which cuts at po-
sition 8993 only if the T to G mutation is present.
Molecular diagnosis revealed mitochondrial T8993C
mutation within the gene coding for ATPase 6 in the girl,
her brother, and her mother but not her father thus conﬁrming
mitochondrial DNA-associated Leigh syndrome in this family.
As the patient’s two sisters were already deceased at the time of
diagnosis and there was no DNA material preserved, molecu-
lar testing was not done to them. The patient and her brother
show roughly 90% mutated mitochondrial DNA while the
mother had only 50% mutated DNA.Discussion
Complex V (ATP synthase) of the mitochondrion comprises
10–16 subunits encoded by nuclear DNA and 2 subunits
(ATPase 6 and ATPase 8) encoded by mtDNA. Subunit 6 of
Hypothyroidism and mitochondrial T8993C mutation 203mitochondrial ATP synthase (complex V) is encoded by nucle-
otides 8527–9207 of the mitochondrial genome. Tatuch et al.
[2] and Shoffner et al. [3] demonstrated that the nucleotide
8993 mutation can cause Leigh syndrome. Defective catalytic
properties of the enzyme complex may result either from an
impairment of proton transport or from impaired coupling
of proton translocation with ATP synthesis [4–7]. White
et al. [8] described 13 pedigrees with mtDNA mutations at
nucleotide 8993: 10 pedigrees with 8993T-G (OMIM
516060.0001) and 3 with 8993T-C (OMIM 516060.0002).
Two main phenotypes were identiﬁed: the typical Neurop-
athy Ataxia Retinitis Pigmentosa (NARP syndrome) [9–11]
and maternally inherited Leigh syndrome [12,13], most of the
cases reported were Juvenile onset type of Leigh syndrome.
Our patient had T8993C mutation which together with
T8993G account for 10–20% of mitochondrial DNA-associ-
ated Leigh syndrome. Though the T8993C mutation is gener-
ally considered to be clinically milder than the T8993G
mutation, the scenario of events in the deceased sisters with
earlier onset of the disease (before their second birthday) con-
tradicts this statement. The increased severity of the disease in
the proband in this case may relate to the very high percentage
of mutated mtDNA (90%).
Although the patient’s brother has the same percentage of
mutated mitochondrial DNA (90%), he had hypothyroidism
which could be the only manifestation of the T8993C muta-
tion. This unusual lack of manifestation could be attributed
to different percentages of mutated mitochondrial DNA in
the brain or muscle or perhaps to some unknown protective
factor. The hypothyroidism could be a simple association,
but to the best of our knowledge, no previous reports have
described hypothyroidism in carriers of this mutation.
Fujii et al. [14] reviewed 10 Leigh syndrome patients with
the 8993T-C mutation and compared them with 18 reported
cases with Leigh syndrome caused by the 8993T-G mutation
(516060.0001). Leigh syndrome with the 8993T-C mutation
was characterized by a signiﬁcantly higher frequency of ataxia.
None of the reviewed 8993T-C Leigh syndrome patients had
retinitis pigmentosa, which is one of the characteristic ﬁndings
in Leigh syndrome caused by the 8993T-G mutation. The
milder symptoms of 8993T-C Leigh syndrome may be ex-
plained by the milder complex V dysfunction.
Debray et al. reviewed 20 Leigh syndrome patients with
the 8993T-C mutation. Only half (10/20) of the patients ful-
ﬁlled the criteria of Rahman et al. [1] for typical Leigh syn-
drome. Eighty-ﬁve percent (17/20) survived a median
follow-up time of 16 years and 41% (7/20) did not have men-
tal retardation. The authors concluded that a favorable out-
come can be observed in a signiﬁcant percentage of Leigh
syndrome patients with the 8993T-C mtDNA mutation [15].
A similar observation was previously noted by Santorelli
and coworkers [16].
In conclusion, we report a family with 8993T-C mitochon-
drial DNA mutation associated with severe (early onset) Leigh
syndrome in one member and hypothyroidism as the only pre-
senting symptom in another member of the family.
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